JRC Publications Repository

JRC Publications Repository > Joint Research Centre > Institute for Transuranium Elements >

Please use this identifier to cite or link to this item: http://publications.jrc.ec.europa.eu/repository/handle/111111111/24473

Title: Is DTPA a good competing chelating agent for Th(IV) in human serum and suitable in targeted alpha therapy?
Authors: LE DU Alicia
SABATIE-GEGOVA Andrea
MORGENSTERN Alfred
MONTAVON Gilles
Citation: JOURNAL OF INORGANIC BIOCHEMISTRY vol. 109 p. 82 - 89
Publisher: ELSEVIER SCIENCE INC
Publication Year: 2012
JRC Publication N°: JRC68039
ISSN: 0162-0134
URI: www.elsevier .com/locate/jinorgbio
http://publications.jrc.ec.europa.eu/repository/handle/111111111/24473
DOI: 10.1016/j.jinorgbio.2011.12.011
Type: Articles in Journals
Appears in Collections:Institute for Transuranium Elements

Files in This Item:

There are no files associated with this item.

Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.

 

The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national.
Powered by DSpace
Top